Journal of the American College of Cardiology, ISSN 0735-1097, 07/2006, Volume 48, Issue 2, pp. 377 - 385
Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality Jérome Larche, Steve Lancel, Sidi Mohamed...
CYCLOPHILIN-D | CARDIAC & CARDIOVASCULAR SYSTEMS | CYCLOSPORINE-A | PEROXYNITRITE | PORE | SEPTIC SHOCK | REPERFUSION | ACUTE ENDOTOXEMIA | CELL-DEATH | PATHOPHYSIOLOGY | INNER | Bronchoalveolar Lavage Fluid | Multiple Organ Failure - metabolism | Permeability - drug effects | Mitochondria, Heart - metabolism | Cyclosporine - pharmacology | Mice, Inbred C57BL | Peritonitis - metabolism | Mice, Transgenic | Mitochondria, Heart - drug effects | Sepsis - physiopathology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Animals | Caspases - metabolism | Sepsis - metabolism | Nitrites - blood | Peritonitis - physiopathology | Intracellular Membranes - drug effects | Mice | In Vitro Techniques | Immunosuppressive Agents - pharmacology | Myocardial Reperfusion Injury - prevention & control | Disease Models, Animal | Heart failure | Prevention | Mortality | Analysis | Membrane potentials | Leukemia | Cyclosporine | Permeability | Health aspects | Septic shock | Studies | Heart | Rodents | Sepsis | Mitochondrial DNA | Laboratory animals | Variance analysis | Deoxyribonucleic acid--DNA | Abdomen
CYCLOPHILIN-D | CARDIAC & CARDIOVASCULAR SYSTEMS | CYCLOSPORINE-A | PEROXYNITRITE | PORE | SEPTIC SHOCK | REPERFUSION | ACUTE ENDOTOXEMIA | CELL-DEATH | PATHOPHYSIOLOGY | INNER | Bronchoalveolar Lavage Fluid | Multiple Organ Failure - metabolism | Permeability - drug effects | Mitochondria, Heart - metabolism | Cyclosporine - pharmacology | Mice, Inbred C57BL | Peritonitis - metabolism | Mice, Transgenic | Mitochondria, Heart - drug effects | Sepsis - physiopathology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Animals | Caspases - metabolism | Sepsis - metabolism | Nitrites - blood | Peritonitis - physiopathology | Intracellular Membranes - drug effects | Mice | In Vitro Techniques | Immunosuppressive Agents - pharmacology | Myocardial Reperfusion Injury - prevention & control | Disease Models, Animal | Heart failure | Prevention | Mortality | Analysis | Membrane potentials | Leukemia | Cyclosporine | Permeability | Health aspects | Septic shock | Studies | Heart | Rodents | Sepsis | Mitochondrial DNA | Laboratory animals | Variance analysis | Deoxyribonucleic acid--DNA | Abdomen
Journal Article
2.
Full Text
Risk of Post-traumatic Stress Symptoms in Family Members of Intensive Care Unit Patients
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 05/2005, Volume 171, Issue 9, pp. 987 - 994
Rationale: Intensive care unit (ICU) admission of a relative is a stressful event that may cause symptoms of post-traumatic stress disorder (PTSD). Objectives:...
Paternalism | Autonomy | Burden | End of life | Decision making | OF-LIFE CARE | TERRORIST ATTACKS | end of life | MECHANICAL VENTILATION | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | burden | autonomy | EVENT SCALE | DECISION-MAKING | RESPIRATORY SYSTEM | decision making | DISORDER | paternalism | END | HOROWITZS IMPACT | CRITICAL CARE MEDICINE | Decision Making | Intensive Care Units | Depression - epidemiology | Health Status Indicators | Humans | Middle Aged | Stress Disorders, Post-Traumatic - epidemiology | Critical Illness | Family Health | Logistic Models | Male | Factor Analysis, Statistical | Anxiety - epidemiology | Adult | Female | Aged | Communication | PTSD | Family Members | French | Treatment | Quality of Life | Adults | Effects | Epidemiology
Paternalism | Autonomy | Burden | End of life | Decision making | OF-LIFE CARE | TERRORIST ATTACKS | end of life | MECHANICAL VENTILATION | FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | burden | autonomy | EVENT SCALE | DECISION-MAKING | RESPIRATORY SYSTEM | decision making | DISORDER | paternalism | END | HOROWITZS IMPACT | CRITICAL CARE MEDICINE | Decision Making | Intensive Care Units | Depression - epidemiology | Health Status Indicators | Humans | Middle Aged | Stress Disorders, Post-Traumatic - epidemiology | Critical Illness | Family Health | Logistic Models | Male | Factor Analysis, Statistical | Anxiety - epidemiology | Adult | Female | Aged | Communication | PTSD | Family Members | French | Treatment | Quality of Life | Adults | Effects | Epidemiology
Journal Article
2017, Perspectives stratégiques, ISBN 9782343115832, 213 pages
Book
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2012, Volume 56, Issue 12, pp. 6175 - 6180
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
STRAINS | INFECTIONS | BETA-LACTAMASE | CYSTIC-FIBROSIS PATIENTS | DISSEMINATION | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | HUNGARY | DNA, Viral - biosynthesis | DNA, Bacterial - biosynthesis | Humans | Pseudomonas aeruginosa - virology | Genotype | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Minisatellite Repeats | Bacteriophages - isolation & purification | Microbial Sensitivity Tests | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Cross Infection - microbiology | Anti-Bacterial Agents - pharmacology | DNA, Viral - genetics | Drug Resistance, Multiple, Bacterial - genetics | France | Life Sciences | Microbiology and Parasitology | Biochemistry, Molecular Biology | Epidemiology and Surveillance
STRAINS | INFECTIONS | BETA-LACTAMASE | CYSTIC-FIBROSIS PATIENTS | DISSEMINATION | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | HUNGARY | DNA, Viral - biosynthesis | DNA, Bacterial - biosynthesis | Humans | Pseudomonas aeruginosa - virology | Genotype | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Minisatellite Repeats | Bacteriophages - isolation & purification | Microbial Sensitivity Tests | DNA, Bacterial - genetics | Pseudomonas aeruginosa - genetics | Cross Infection - microbiology | Anti-Bacterial Agents - pharmacology | DNA, Viral - genetics | Drug Resistance, Multiple, Bacterial - genetics | France | Life Sciences | Microbiology and Parasitology | Biochemistry, Molecular Biology | Epidemiology and Surveillance
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 10/2003, Volume 29, Issue 10, pp. 1688 - 1695
To identify predictors of 30-day mortality in critically ill cancer patients with septic shock.Retrospective study over a 6-year period.Twelve-bed medical...
Medicine | LOD score | Antibiotics | Mortality | Treatment delays | Septic shock | Critically ill cancer patients | septic shock | RISK-FACTORS | PROGNOSTIC-FACTORS | MECHANICAL VENTILATION | SHORT-TERM MORTALITY | NEUTROPENIC PATIENTS | ICU PATIENTS | treatment delays | BONE-MARROW TRANSPLANTATION | INTENSIVE-CARE-UNIT | ACUTE PHYSIOLOGY | critically ill cancer patients | mortality | antibiotics | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Prognosis | Humans | Middle Aged | Critical Illness | Neoplasms - mortality | Shock, Septic - complications | Male | Survival Rate | Shock, Septic - mortality | Neoplasms - complications | Time Factors | Adult | Critical Care | Female | Retrospective Studies | Care and treatment | Critically ill | Patient outcomes | France | Health aspects | Risk factors
Medicine | LOD score | Antibiotics | Mortality | Treatment delays | Septic shock | Critically ill cancer patients | septic shock | RISK-FACTORS | PROGNOSTIC-FACTORS | MECHANICAL VENTILATION | SHORT-TERM MORTALITY | NEUTROPENIC PATIENTS | ICU PATIENTS | treatment delays | BONE-MARROW TRANSPLANTATION | INTENSIVE-CARE-UNIT | ACUTE PHYSIOLOGY | critically ill cancer patients | mortality | antibiotics | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Prognosis | Humans | Middle Aged | Critical Illness | Neoplasms - mortality | Shock, Septic - complications | Male | Survival Rate | Shock, Septic - mortality | Neoplasms - complications | Time Factors | Adult | Critical Care | Female | Retrospective Studies | Care and treatment | Critically ill | Patient outcomes | France | Health aspects | Risk factors
Journal Article
Cancer, ISSN 0008-543X, 12/2007, Volume 110, Issue 12, pp. 2740 - 2746
BACKGROUND. invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to...
Drug combination | Liposomal amphotericin B | Invasive aspergillosis | Antifungal treatment | Caspofungin | VORICONAZOLE | liposomal amphotericin B | LIPID COMPLEX | EFFICACY | SAFETY | antifungal treatment | drug combination | TOXICITY | PNEUMONIA | caspofungin | FUNGAL-INFECTIONS | ACUTE-LEUKEMIA | invasive aspergillosis | ONCOLOGY | NEUTROPENIA | ANTIFUNGAL THERAPY | Humans | Middle Aged | Male | Treatment Outcome | Amphotericin B - adverse effects | Echinocandins - administration & dosage | Pilot Projects | Echinocandins - adverse effects | Adolescent | Amphotericin B - administration & dosage | Adult | Female | Aged | Hematologic Neoplasms - complications | Drug Therapy, Combination | Lipopeptides | Aspergillosis - complications | Aspergillosis - drug therapy | Usage | Amphotericin B | Patient outcomes | Aspergillosis | Physiological aspects | Dosage and administration | Drug therapy, Combination | Research | Liposomes | Drug therapy | Blood diseases
Drug combination | Liposomal amphotericin B | Invasive aspergillosis | Antifungal treatment | Caspofungin | VORICONAZOLE | liposomal amphotericin B | LIPID COMPLEX | EFFICACY | SAFETY | antifungal treatment | drug combination | TOXICITY | PNEUMONIA | caspofungin | FUNGAL-INFECTIONS | ACUTE-LEUKEMIA | invasive aspergillosis | ONCOLOGY | NEUTROPENIA | ANTIFUNGAL THERAPY | Humans | Middle Aged | Male | Treatment Outcome | Amphotericin B - adverse effects | Echinocandins - administration & dosage | Pilot Projects | Echinocandins - adverse effects | Adolescent | Amphotericin B - administration & dosage | Adult | Female | Aged | Hematologic Neoplasms - complications | Drug Therapy, Combination | Lipopeptides | Aspergillosis - complications | Aspergillosis - drug therapy | Usage | Amphotericin B | Patient outcomes | Aspergillosis | Physiological aspects | Dosage and administration | Drug therapy, Combination | Research | Liposomes | Drug therapy | Blood diseases
Journal Article
Critical Care, ISSN 1364-8535, 02/2012, Volume 16, Issue 1, pp. R34 - R34
Introduction: The causative role of new hydroxyethyl starch (HES 130/0.4) in renal dysfunction frequency (a > 50% increase in serum creatinine or need for...
ACUTE KIDNEY INJURY | MULTICENTER | THERAPY | INTENSIVE-CARE-UNIT | HYDROXYETHYLSTARCH | SURVIVING SEPSIS | CRITICALLY-ILL PATIENTS | FAILURE | CARDIAC RESPONSE | RESUSCITATION | CRITICAL CARE MEDICINE | Kidney - physiology | Kidney - drug effects | Humans | Hydroxyethyl Starch Derivatives - administration & dosage | Middle Aged | Risk Factors | Male | Shock, Septic - mortality | Fluid Therapy - adverse effects | Shock, Septic - therapy | Sepsis - mortality | Acute Kidney Injury - mortality | Sepsis - therapy | Sex Factors | Female | Acute Kidney Injury - chemically induced | Aged | Disease Management | Hydroxyethyl Starch Derivatives - adverse effects | Usage | Kidney failure | Research | Hydration | Risk factors | Life Sciences | Human health and pathology
ACUTE KIDNEY INJURY | MULTICENTER | THERAPY | INTENSIVE-CARE-UNIT | HYDROXYETHYLSTARCH | SURVIVING SEPSIS | CRITICALLY-ILL PATIENTS | FAILURE | CARDIAC RESPONSE | RESUSCITATION | CRITICAL CARE MEDICINE | Kidney - physiology | Kidney - drug effects | Humans | Hydroxyethyl Starch Derivatives - administration & dosage | Middle Aged | Risk Factors | Male | Shock, Septic - mortality | Fluid Therapy - adverse effects | Shock, Septic - therapy | Sepsis - mortality | Acute Kidney Injury - mortality | Sepsis - therapy | Sex Factors | Female | Acute Kidney Injury - chemically induced | Aged | Disease Management | Hydroxyethyl Starch Derivatives - adverse effects | Usage | Kidney failure | Research | Hydration | Risk factors | Life Sciences | Human health and pathology
Journal Article
Cancer, ISSN 0008-543X, 12/2007, Volume 110, Issue 12, pp. 2740 - 2746
BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to...
liposomal amphotericin B | invasive aspergillosis | caspofungin | antifungal treatment | drug combination
liposomal amphotericin B | invasive aspergillosis | caspofungin | antifungal treatment | drug combination
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 03/2006, Volume 44, Issue 3, pp. 805 - 810
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
CELL TRANSPLANT RECIPIENTS | DIAGNOSIS | INFECTIONS | POSACONAZOLE | ZYGOMYCOSIS | RECEIVING VORICONAZOLE PROPHYLAXIS | CARE CANCER CENTER | MICROBIOLOGY | RIBOSOMAL-RNA GENE | MUCORMYCOSIS | EPIDEMIOLOGY | Mucorales - isolation & purification | DNA, Fungal - genetics | Mucormycosis - diagnosis | Humans | Middle Aged | Molecular Sequence Data | Male | Mucorales - pathogenicity | DNA Primers - genetics | Mucorales - genetics | Sequence Homology, Nucleic Acid | Mucorales - classification | Opportunistic Infections - diagnosis | Opportunistic Infections - microbiology | Polymerase Chain Reaction - methods | Polymorphism, Restriction Fragment Length | Virulence - genetics | Mucormycosis - microbiology | Base Sequence | Adult | Female | Retrospective Studies | Mycology
CELL TRANSPLANT RECIPIENTS | DIAGNOSIS | INFECTIONS | POSACONAZOLE | ZYGOMYCOSIS | RECEIVING VORICONAZOLE PROPHYLAXIS | CARE CANCER CENTER | MICROBIOLOGY | RIBOSOMAL-RNA GENE | MUCORMYCOSIS | EPIDEMIOLOGY | Mucorales - isolation & purification | DNA, Fungal - genetics | Mucormycosis - diagnosis | Humans | Middle Aged | Molecular Sequence Data | Male | Mucorales - pathogenicity | DNA Primers - genetics | Mucorales - genetics | Sequence Homology, Nucleic Acid | Mucorales - classification | Opportunistic Infections - diagnosis | Opportunistic Infections - microbiology | Polymerase Chain Reaction - methods | Polymorphism, Restriction Fragment Length | Virulence - genetics | Mucormycosis - microbiology | Base Sequence | Adult | Female | Retrospective Studies | Mycology
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 1996, Volume 9, Issue 7, pp. 633 - 643
Medications given once daily may increase compliance for treatment of hypertension, if the drugs have a prolonged duration of action. The time- effect profiles...
antihypertensive drugs | Trough/peak | clinical trials | angiotensin converting enzyme inhibitors | calcium antagonists | ONCE-DAILY LISINOPRIL | trough/peak | CIRCADIAN-RHYTHMS | SYSTEMIC HYPERTENSION | DAILY DILTIAZEM | SLOW-RELEASE | MG CILAZAPRIL | EXTENDED-RELEASE FELODIPINE | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | TO-MODERATE HYPERTENSION | AMBULATORY BLOOD-PRESSURE | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Humans | Calcium Channel Blockers - administration & dosage | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Blood Pressure - drug effects | Blood Pressure - physiology | Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics | Calcium Channel Blockers - pharmacokinetics | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology
antihypertensive drugs | Trough/peak | clinical trials | angiotensin converting enzyme inhibitors | calcium antagonists | ONCE-DAILY LISINOPRIL | trough/peak | CIRCADIAN-RHYTHMS | SYSTEMIC HYPERTENSION | DAILY DILTIAZEM | SLOW-RELEASE | MG CILAZAPRIL | EXTENDED-RELEASE FELODIPINE | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | TO-MODERATE HYPERTENSION | AMBULATORY BLOOD-PRESSURE | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Humans | Calcium Channel Blockers - administration & dosage | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Blood Pressure - drug effects | Blood Pressure - physiology | Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics | Calcium Channel Blockers - pharmacokinetics | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Hypertension - physiopathology
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2005, Volume 41, Issue 9, pp. 1362 - 1365
Polymerase chain reaction | Antifungals | Mucormycosis | Biological taxonomies | Mucorales | Restriction fragment length polymorphism | Rhizopus | Mycology | Correspondence | Infections | Lesions | RECIPIENTS RECEIVING VORICONAZOLE | INFECTIOUS DISEASES | MICROBIOLOGY | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ZYGOMYCOSIS | Rhizopus - genetics | Polymorphism, Restriction Fragment Length | Mucormycosis - diagnosis | Humans | Middle Aged | Female | Dermatomycoses - diagnosis | Polymerase Chain Reaction - methods | Usage | Diagnosis | Risk factors | Genetic polymorphisms
Journal Article
NACE - International Corrosion Conference Series, ISSN 0361-4409, 2016, Volume 1, pp. 779 - 792
Conference Proceeding
Humanitaire, ISSN 1624-4184, 04/2007, Volume 16, pp. 96 - 101
Au cours des 10 dernières années, plus de 1100 humanitaires ont été tués durant des attaques sur des opérations d'aide aux populations civiles. Si, d'après le...
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 1996, Volume 9, Issue 7, pp. 633 - 643
Journal Article
Journal of Scleroderma and Related Disorders, ISSN 2397-1983, 2017, Volume 2, Issue 3, pp. 169 - 182
Journal Article
2003, 1, ISBN 1900650614, 239
This book, the English version of La traduction aujourd'hui (Hachette 1994), describes the interpretive theory of translation developed at the Paris Ecole...
Translating and interpreting | Translation
Translating and interpreting | Translation
Book
2014, ISBN 1900650614
Web Resource
04/2014, ISBN 9781900650618, 12
This book, the English version of La traduction aujourd'hui (Hachette 1994), describes the interpretive theory of translation developed at the Paris Ecole...
Translation | Translating and interpreting
Translation | Translating and interpreting
eBook
20.
Full Text
Fluid challenges in intensive care: the FENICE study
: A global inception cohort study
Intensive Care Medicine, ISSN 0342-4642, 9/2015, Volume 41, Issue 9, pp. 1529 - 1537
Fluid challenges (FCs) are one of the most commonly used therapies in critically ill patients and represent the cornerstone of hemodynamic management in...
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | RESPONSIVENESS | TASK-FORCE | ARTERIAL-PRESSURE | CIRCULATORY SHOCK | SEPTIC SHOCK | HYDROXYETHYL STARCH 130/0.4 | OF-THE-LITERATURE | RENAL REPLACEMENT THERAPY | CRITICALLY-ILL PATIENTS | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Fluid Therapy | Humans | Middle Aged | Critical Care | Female | Male | Practice Patterns, Physicians | Cohort Studies | Life Sciences | Human health and pathology | Seven-Day Profile Publication
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | RESPONSIVENESS | TASK-FORCE | ARTERIAL-PRESSURE | CIRCULATORY SHOCK | SEPTIC SHOCK | HYDROXYETHYL STARCH 130/0.4 | OF-THE-LITERATURE | RENAL REPLACEMENT THERAPY | CRITICALLY-ILL PATIENTS | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Fluid Therapy | Humans | Middle Aged | Critical Care | Female | Male | Practice Patterns, Physicians | Cohort Studies | Life Sciences | Human health and pathology | Seven-Day Profile Publication
Journal Article